InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ANAPTYSBIO, INC

ANAB Clue Score43
United States Fiscal year ends June CIK 0001370053 Results filed 12 May 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

23
Insider
Date
Role
Action
Shares
Price
Amount
EcoR1 Capital, LLC
2 Jan 2025
Director
Buy indirect
6,646
$12.95
$86.07K
EcoR1 Capital, LLC
31 Dec 2024
Director
Buy indirect
13,268
$12.93
$171.51K
EcoR1 Capital, LLC
30 Dec 2024
Director
Buy indirect
65,184
$12.92
$842.06K
EcoR1 Capital, LLC
14 Aug 2024
10% owner
Buy indirect
273,972
$36.50
$10.00M
EcoR1 Capital, LLC
5 May 2022
10% owner
Buy indirect
668,237
$21.63
$14.45M
EcoR1 Capital, LLC
4 May 2021
Director
Buy indirect
165,000
$23.25
$3.84M
EcoR1 Capital, LLC
3 May 2021
Director
Buy indirect
20,800
$23.31
$484.87K
EcoR1 Capital, LLC
30 Apr 2021
Director
Buy indirect
35,700
$23.16
$826.82K
EcoR1 Capital, LLC
27 Apr 2021
Director
Buy indirect
33,800
$23.82
$805.09K
EcoR1 Capital, LLC
26 Apr 2021
Director
Buy indirect
13,900
$23.80
$330.86K
EcoR1 Capital, LLC
23 Apr 2021
Director
Buy indirect
99,600
$23.54
$2.34M
EcoR1 Capital, LLC
9 Mar 2021
10% owner
Buy indirect
531,000
$18.70
$9.93M
EcoR1 Capital, LLC
8 Mar 2021
10% owner
Buy indirect
2,777,800
$18.97
$52.69M
EcoR1 Capital, LLC
23 Feb 2021
10% owner
Buy indirect
29,500
$25.48
$751.66K
J. Anthony Ware
10 Dec 2019
Director
Buy
3,600
$14.05
$50.58K
Frazier Healthcare V, LP
31 Jan 2017
10% owner
Buy indirect
88,709
$15.00
$1.33M
Frazier Healthcare V, LP
31 Jan 2017
10% owner
Buy indirect
311,291
$15.00
$4.67M
Frazier Healthcare VII, L.P.
31 Jan 2017
10% owner
Buy indirect
88,709
$15.00
$1.33M
Frazier Healthcare VII, L.P.
31 Jan 2017
10% owner
Buy
311,291
$15.00
$4.67M
Nicholas Lydon
31 Jan 2017
Director
Buy
16,666
$15.00
$249.99K
James N Topper
31 Jan 2017
Director
Buy indirect
88,709
$15.00
$1.33M
James N Topper
31 Jan 2017
Director
Buy indirect
311,291
$15.00
$4.67M
Novo Holdings A/S
31 Jan 2017
10% owner
Buy
50,000
$15.00
$750.00K
Show all 180 transactions →

What was left out

Form 4 filings counted 265
Amendments (4/A) skipped 1
Filings about a different issuer 1
Unreadable filings 0
Joint filings 11
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 68
Sales at will 66
Transactions with no price 0
Shares from compensation/vesting 22,378,949
Sales filed before the plan box existed 26
History held since 31 Jan 2017